Q3 2023 Holdings
Filed 2023-11-14 | 46 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Coursera Inc(COUR) | COM | 22266M104 | $240.5M | 12,867,769 | 18.6% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $134.4M | 3,745,262 | 10.4% |
| Savara Inc(SVRA) | COM | 805111101 | $92.5M | 24,471,264 | 7.1% |
| Verona Pharma PLC(VRNA) | SPONSERED ADS | 925050106 | $91.0M | 5,108,563 | 7.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $72.1M | 1,587,854 | 5.6% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $69.1M | 2,186,243 | 5.3% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $66.7M | 2,909,956 | 5.2% |
| Geron Corp(GERN) | COM | 374163103 | $48.3M | 22,776,409 | 3.7% |
| Nextnav Inc(NN) | COMMON STOCK | 65345N106 | $42.1M | 8,189,156 | 3.3% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $36.8M | 7,692,298 | 2.8% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $36.4M | 4,785,494 | 2.8% |
| Cvrx Inc(CVRX) | COM | 126638105 | $36.0M | 2,370,542 | 2.8% |
| Celcuity Inc(CELC) | COM | 15102K100 | $31.8M | 1,250,001 | 2.5% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $30.8M | 3,969,834 | 2.4% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $27.1M | 3,850,275 | 2.1% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $24.8M | 11,370,376 | 1.9% |
| Desktop Metal Inc | COM CL A | 25058X105 | $21.0M | 14,407,594 | 1.6% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $16.3M | 14,986,793 | 1.3% |
| Bright Health Group Inc | COM NEW | 10920V404 | $16.3M | 2,726,917 | 1.3% |
| Zerofox Hldgs Inc | COM | 98955G103 | $15.9M | 18,068,513 | 1.2% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $14.0M | 6,147,260 | 1.1% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $13.3M | 17,079,778 | 1.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $13.1M | 15,727,942 | 1.0% |
| Black Diamond Therapeutics Inc(BDTX) | COM | 09203E105 | $12.8M | 4,448,757 | 1.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $12.2M | 1,276,595 | 0.9% |
| Champions Oncology Inc(CSBR) | COM NEW | 15870P307 | $10.6M | 1,713,720 | 0.8% |
| Inozyme Pharma Inc | COM | 45790W108 | $10.2M | 2,437,689 | 0.8% |
| Tuya Inc(TUYA) | SPONSERED ADS | 90114C107 | $7.6M | 4,934,640 | 0.6% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $7.1M | 4,764,440 | 0.6% |
| Inventiva SA(IVA) | ADS | 46124U107 | $6.3M | 1,462,586 | 0.5% |
| Buzzfeed Inc | CLASS A COM | 12430A102 | $5.9M | 15,333,892 | 0.5% |
| Minerva Surgical Inc | COM | 60343F106 | $5.7M | 34,437,052 | 0.4% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $5.0M | 3,568,781 | 0.4% |
| Marker Therapeutics Inc(MRKR) | COM NEW | 57055L206 | $4.9M | 1,071,428 | 0.4% |
| Acrivon Therapeutics Inc(ACRV) | COMMON STOCK | 004890109 | $4.1M | 430,252 | 0.3% |
| Regulus Therapeutics Inc | COM | 75915K200 | $2.7M | 1,945,579 | 0.2% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $2.6M | 2,382,286 | 0.2% |
| Affimed NV | COM | N01045108 | $2.1M | 4,426,488 | 0.2% |
| Senti Biosciences Inc | COM | 81726A100 | $1.8M | 4,426,151 | 0.1% |
| Ikena Oncology Inc | COM | 45175G108 | $707.2K | 181,473 | 0.1% |
| Synlogic Inc(SYBX) | COM NEW | 87166L209 | $614.6K | 281,929 | 0.0% |
| Surf AIR Mobility Inc | COM | 868927104 | $610.2K | 440,418 | 0.0% |
| Addex Therapeutics LTD(ADXNUSD) | SPONSORED ADS | 00654J107 | $408.3K | 180,000 | 0.0% |
| Wheels UP Experience Inc(UP) | COM CL A | 96328L205 | $219.7K | 106,126 | 0.0% |
| Eargo Inc | COM NEW | 270087208 | $188.8K | 86,946 | 0.0% |
| Akari Therapeutics PLC(AKTX) | SPONSORED ADR | 00972G207 | $89.3K | 22,608 | 0.0% |